Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Silencing of DLGAP5 by siRNA significantly inhibits the proliferation and invasion of hepatocellular carcinoma cells.

Liao W, Liu W, Yuan Q, Liu X, Ou Y, He S, Yuan S, Qin L, Chen Q, Nong K, Mei M, Huang J.

PLoS One. 2013 Dec 4;8(12):e80789. doi: 10.1371/journal.pone.0080789. eCollection 2013.

PMID:
24324629
2.

Down-regulation of SFRP1 as a putative tumor suppressor gene can contribute to human hepatocellular carcinoma.

Huang J, Zhang YL, Teng XM, Lin Y, Zheng DL, Yang PY, Han ZG.

BMC Cancer. 2007 Jul 12;7:126.

PMID:
17626620
3.

Reduced expression of DACT2 promotes hepatocellular carcinoma progression: involvement of methylation-mediated gene silencing.

Gao S, Yang Z, Zheng ZY, Yao J, Zhang F, Wu LM, Xie HY, Zhou L, Zheng SS.

World J Surg Oncol. 2013 Mar 7;11:57. doi: 10.1186/1477-7819-11-57.

PMID:
23496880
4.

Expression of a novel gene FAM43B repressing cell proliferation is regulated by DNA methylation in hepatocellular carcinoma cell lines.

Xu X, Liu RF, Wan BB, Xing WM, Huang J, Han ZG.

Mol Cell Biochem. 2011 Aug;354(1-2):11-20. doi: 10.1007/s11010-011-0800-y. Epub 2011 Apr 2.

PMID:
21461611
5.

The suppressive role and aberrent promoter methylation of BTG3 in the progression of hepatocellular carcinoma.

Lv Z, Zou H, Peng K, Wang J, Ding Y, Li Y, Ren X, Wang F, Chang R, Liang L, Ding Y.

PLoS One. 2013 Oct 17;8(10):e77473. doi: 10.1371/journal.pone.0077473. eCollection 2013.

PMID:
24147003
6.

Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.

Zhang XF, Chao J, Pan QZ, Pan K, Weng DS, Wang QJ, Zhao JJ, He J, Liu Q, Jiang SS, Chen CL, Zhang HX, Xia JC.

Oncotarget. 2015 Dec 1;6(38):40920-33. doi: 10.18632/oncotarget.5712.

PMID:
26506518
7.

Upregulation of FAM83D affects the proliferation and invasion of hepatocellular carcinoma.

Liao W, Liu W, Liu X, Yuan Q, Ou Y, Qi Y, Huang W, Wang Y, Huang J.

Oncotarget. 2015 Sep 15;6(27):24132-47.

PMID:
26125229
8.

ESM-1 silencing decreased cell survival, migration, and invasion and modulated cell cycle progression in hepatocellular carcinoma.

Kang YH, Ji NY, Lee CI, Lee HG, Kim JW, Yeom YI, Kim DG, Yoon SK, Kim JW, Park PJ, Song EY.

Amino Acids. 2011 Mar;40(3):1003-13. doi: 10.1007/s00726-010-0729-6. Epub 2010 Sep 7.

PMID:
20821239
9.

Upregulator of cell proliferation predicts poor prognosis in hepatocellular carcinoma and contributes to hepatocarcinogenesis by downregulating FOXO3a.

Xie C, Song LB, Wu JH, Li J, Yun JP, Lai JM, Xie DY, Lin BL, Yuan YF, Li M, Gao ZL.

PLoS One. 2012;7(7):e40607. doi: 10.1371/journal.pone.0040607. Epub 2012 Jul 16.

PMID:
22815774
10.

Identification of LZAP as a new candidate tumor suppressor in hepatocellular carcinoma.

Zhao JJ, Pan K, Li JJ, Chen YB, Chen JG, Lv L, Wang DD, Pan QZ, Chen MS, Xia JC.

PLoS One. 2011;6(10):e26608. doi: 10.1371/journal.pone.0026608. Epub 2011 Oct 19.

PMID:
22028922
11.

Promoter hypomethylation up-regulates CD147 expression through increasing Sp1 binding and associates with poor prognosis in human hepatocellular carcinoma.

Kong LM, Liao CG, Chen L, Yang HS, Zhang SH, Zhang Z, Bian HJ, Xing JL, Chen ZN.

J Cell Mol Med. 2011 Jun;15(6):1415-28. doi: 10.1111/j.1582-4934.2010.01124.x. Epub 2010 Jul 12.

PMID:
20629990
12.

RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma.

Wang F, Feng Y, Li P, Wang K, Feng L, Liu YF, Huang H, Guo YB, Mao QS, Xue WJ.

Oncotarget. 2016 Jan 26;7(4):4279-97. doi: 10.18632/oncotarget.6654.

PMID:
26701853
13.

Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.

Tu K, Dou C, Zheng X, Li C, Yang W, Yao Y, Liu Q.

BMC Cancer. 2014 Dec 12;14:938. doi: 10.1186/1471-2407-14-938.

PMID:
25494879
14.

miR-129 suppresses tumor cell growth and invasion by targeting PAK5 in hepatocellular carcinoma.

Zhai J, Qu S, Li X, Zhong J, Chen X, Qu Z, Wu D.

Biochem Biophys Res Commun. 2015 Aug 14;464(1):161-7. doi: 10.1016/j.bbrc.2015.06.108. Epub 2015 Jun 23.

PMID:
26116538
15.

Cyr61/CCN1 is a tumor suppressor in human hepatocellular carcinoma and involved in DNA damage response.

Feng P, Wang B, Ren EC.

Int J Biochem Cell Biol. 2008;40(1):98-109. Epub 2007 Jul 26.

PMID:
17698398
16.

The RNA-binding protein Sam68 regulates tumor cell viability and hepatic carcinogenesis by inhibiting the transcriptional activity of FOXOs.

Zhang T, Wan C, Shi W, Xu J, Fan H, Zhang S, Lin Z, Ni R, Zhang X.

J Mol Histol. 2015 Dec;46(6):485-97. doi: 10.1007/s10735-015-9639-y. Epub 2015 Oct 5.

PMID:
26438629
17.

TRIM26 functions as a novel tumor suppressor of hepatocellular carcinoma and its downregulation contributes to worse prognosis.

Wang Y, He D, Yang L, Wen B, Dai J, Zhang Q, Kang J, He W, Ding Q, He D.

Biochem Biophys Res Commun. 2015 Jul 31;463(3):458-65. doi: 10.1016/j.bbrc.2015.05.117. Epub 2015 Jun 1.

PMID:
26043685
18.

Up-regulated expression of stathmin may be associated with hepatocarcinogenesis.

Gan L, Guo K, Li Y, Kang X, Sun L, Shu H, Liu Y.

Oncol Rep. 2010 Apr;23(4):1037-43.

PMID:
20204289
19.

CUL4A facilitates hepatocarcinogenesis by promoting cell cycle progression and epithelial-mesenchymal transition.

Pan Y, Wang B, Yang X, Bai F, Xu Q, Li X, Gao L, Ma C, Liang X.

Sci Rep. 2015 Nov 23;5:17006. doi: 10.1038/srep17006.

PMID:
26593394
20.

TTK activates Akt and promotes proliferation and migration of hepatocellular carcinoma cells.

Liu X, Liao W, Yuan Q, Ou Y, Huang J.

Oncotarget. 2015 Oct 27;6(33):34309-20. doi: 10.18632/oncotarget.5295.

PMID:
26418879

Supplemental Content

Support Center